nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ALB—stomach cancer	0.265	1	CbGaD
Alfentanil—ABCB1—Mitomycin—stomach cancer	0.0989	0.173	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0519	0.0907	CbGbCtD
Alfentanil—CYP3A7—Irinotecan—stomach cancer	0.0519	0.0907	CbGbCtD
Alfentanil—ALB—Irinotecan—stomach cancer	0.0485	0.0846	CbGbCtD
Alfentanil—ALB—Fluorouracil—stomach cancer	0.0465	0.0812	CbGbCtD
Alfentanil—CYP3A5—Irinotecan—stomach cancer	0.039	0.068	CbGbCtD
Alfentanil—CYP3A7—Docetaxel—stomach cancer	0.0381	0.0664	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0381	0.0664	CbGbCtD
Alfentanil—CYP3A5—Docetaxel—stomach cancer	0.0286	0.0498	CbGbCtD
Alfentanil—ALB—Methotrexate—stomach cancer	0.0257	0.0448	CbGbCtD
Alfentanil—ABCB1—Irinotecan—stomach cancer	0.0254	0.0443	CbGbCtD
Alfentanil—ABCB1—Docetaxel—stomach cancer	0.0186	0.0324	CbGbCtD
Alfentanil—CYP3A4—Irinotecan—stomach cancer	0.0152	0.0265	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—stomach cancer	0.0139	0.0242	CbGbCtD
Alfentanil—ABCB1—Methotrexate—stomach cancer	0.0134	0.0234	CbGbCtD
Alfentanil—CYP3A4—Docetaxel—stomach cancer	0.0111	0.0194	CbGbCtD
Alfentanil—ORM1—bile—stomach cancer	0.0103	0.274	CbGeAlD
Alfentanil—CYP3A4—Doxorubicin—stomach cancer	0.0083	0.0145	CbGbCtD
Alfentanil—ORM1—gall bladder—stomach cancer	0.00286	0.0761	CbGeAlD
Alfentanil—ALB—gall bladder—stomach cancer	0.00251	0.0667	CbGeAlD
Alfentanil—OPRM1—hematopoietic system—stomach cancer	0.00166	0.0441	CbGeAlD
Alfentanil—ORM1—hematopoietic system—stomach cancer	0.00162	0.0431	CbGeAlD
Alfentanil—CYP3A7—endocrine gland—stomach cancer	0.00147	0.0391	CbGeAlD
Alfentanil—CYP3A7—liver—stomach cancer	0.00132	0.0353	CbGeAlD
Alfentanil—CYP3A7-CYP3A51P—liver—stomach cancer	0.00113	0.03	CbGeAlD
Alfentanil—ORM1—bone marrow—stomach cancer	0.00104	0.0276	CbGeAlD
Alfentanil—OPRM1—endocrine gland—stomach cancer	0.000953	0.0254	CbGeAlD
Alfentanil—ORM1—endocrine gland—stomach cancer	0.00093	0.0247	CbGeAlD
Alfentanil—CYP3A5—hematopoietic system—stomach cancer	0.0009	0.024	CbGeAlD
Alfentanil—ABCB1—blood vessel—stomach cancer	0.000898	0.0239	CbGeAlD
Alfentanil—ORM1—liver—stomach cancer	0.000838	0.0223	CbGeAlD
Alfentanil—ALB—liver—stomach cancer	0.000735	0.0196	CbGeAlD
Alfentanil—CYP3A5—pancreas—stomach cancer	0.000733	0.0195	CbGeAlD
Alfentanil—CYP3A4—hematopoietic system—stomach cancer	0.000675	0.018	CbGeAlD
Alfentanil—ORM1—lymph node—stomach cancer	0.000643	0.0171	CbGeAlD
Alfentanil—CYP3A5—digestive system—stomach cancer	0.000626	0.0167	CbGeAlD
Alfentanil—ALB—lymph node—stomach cancer	0.000564	0.015	CbGeAlD
Alfentanil—CYP3A5—endocrine gland—stomach cancer	0.000517	0.0138	CbGeAlD
Alfentanil—ABCB1—hematopoietic system—stomach cancer	0.000478	0.0127	CbGeAlD
Alfentanil—CYP3A4—digestive system—stomach cancer	0.00047	0.0125	CbGeAlD
Alfentanil—CYP3A5—liver—stomach cancer	0.000466	0.0124	CbGeAlD
Alfentanil—ABCB1—epithelium—stomach cancer	0.000437	0.0116	CbGeAlD
Alfentanil—Loss of consciousness—Irinotecan—stomach cancer	0.000403	0.0035	CcSEcCtD
Alfentanil—Visual disturbance—Methotrexate—stomach cancer	0.000401	0.00348	CcSEcCtD
Alfentanil—Cough—Irinotecan—stomach cancer	0.000401	0.00348	CcSEcCtD
Alfentanil—Hypertension—Irinotecan—stomach cancer	0.000396	0.00344	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Methotrexate—stomach cancer	0.000392	0.00341	CcSEcCtD
Alfentanil—ABCB1—pancreas—stomach cancer	0.000389	0.0104	CbGeAlD
Alfentanil—CYP3A4—endocrine gland—stomach cancer	0.000388	0.0103	CbGeAlD
Alfentanil—Epistaxis—Docetaxel—stomach cancer	0.000383	0.00333	CcSEcCtD
Alfentanil—Convulsion—Fluorouracil—stomach cancer	0.000381	0.00331	CcSEcCtD
Alfentanil—Confusional state—Irinotecan—stomach cancer	0.000378	0.00328	CcSEcCtD
Alfentanil—Anaphylactic shock—Irinotecan—stomach cancer	0.000375	0.00325	CcSEcCtD
Alfentanil—Epistaxis—Capecitabine—stomach cancer	0.000371	0.00322	CcSEcCtD
Alfentanil—Nervous system disorder—Irinotecan—stomach cancer	0.000367	0.00319	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Epirubicin—stomach cancer	0.000367	0.00319	CcSEcCtD
Alfentanil—Hyperhidrosis—Irinotecan—stomach cancer	0.000362	0.00315	CcSEcCtD
Alfentanil—Confusional state—Fluorouracil—stomach cancer	0.000362	0.00314	CcSEcCtD
Alfentanil—Bradycardia—Capecitabine—stomach cancer	0.000359	0.00312	CcSEcCtD
Alfentanil—Anaphylactic shock—Fluorouracil—stomach cancer	0.000359	0.00312	CcSEcCtD
Alfentanil—Connective tissue disorder—Docetaxel—stomach cancer	0.000358	0.00311	CcSEcCtD
Alfentanil—Nervous system disorder—Fluorouracil—stomach cancer	0.000352	0.00306	CcSEcCtD
Alfentanil—Visual impairment—Docetaxel—stomach cancer	0.000351	0.00305	CcSEcCtD
Alfentanil—Tachycardia—Fluorouracil—stomach cancer	0.00035	0.00304	CcSEcCtD
Alfentanil—Hypotension—Irinotecan—stomach cancer	0.00035	0.00304	CcSEcCtD
Alfentanil—CYP3A4—liver—stomach cancer	0.00035	0.00931	CbGeAlD
Alfentanil—Connective tissue disorder—Capecitabine—stomach cancer	0.000347	0.00301	CcSEcCtD
Alfentanil—Eye disorder—Docetaxel—stomach cancer	0.000341	0.00296	CcSEcCtD
Alfentanil—Visual impairment—Capecitabine—stomach cancer	0.00034	0.00295	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.00034	0.00295	CcSEcCtD
Alfentanil—Cardiac disorder—Docetaxel—stomach cancer	0.000338	0.00294	CcSEcCtD
Alfentanil—Cardiac arrest—Epirubicin—stomach cancer	0.000338	0.00294	CcSEcCtD
Alfentanil—ABCB1—lymphoid tissue—stomach cancer	0.000337	0.00896	CbGeAlD
Alfentanil—Hypotension—Fluorouracil—stomach cancer	0.000335	0.00291	CcSEcCtD
Alfentanil—Somnolence—Irinotecan—stomach cancer	0.000333	0.00289	CcSEcCtD
Alfentanil—ABCB1—digestive system—stomach cancer	0.000333	0.00885	CbGeAlD
Alfentanil—Angiopathy—Docetaxel—stomach cancer	0.000331	0.00287	CcSEcCtD
Alfentanil—Eye disorder—Capecitabine—stomach cancer	0.00033	0.00286	CcSEcCtD
Alfentanil—Immune system disorder—Docetaxel—stomach cancer	0.000329	0.00286	CcSEcCtD
Alfentanil—Mediastinal disorder—Docetaxel—stomach cancer	0.000329	0.00285	CcSEcCtD
Alfentanil—Cardiac disorder—Capecitabine—stomach cancer	0.000328	0.00285	CcSEcCtD
Alfentanil—Chills—Docetaxel—stomach cancer	0.000327	0.00284	CcSEcCtD
Alfentanil—Arrhythmia—Docetaxel—stomach cancer	0.000326	0.00283	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000323	0.00281	CcSEcCtD
Alfentanil—Fatigue—Irinotecan—stomach cancer	0.000323	0.00281	CcSEcCtD
Alfentanil—Pain—Irinotecan—stomach cancer	0.00032	0.00278	CcSEcCtD
Alfentanil—Angiopathy—Capecitabine—stomach cancer	0.00032	0.00278	CcSEcCtD
Alfentanil—Mental disorder—Docetaxel—stomach cancer	0.000319	0.00277	CcSEcCtD
Alfentanil—Somnolence—Fluorouracil—stomach cancer	0.000319	0.00277	CcSEcCtD
Alfentanil—Immune system disorder—Capecitabine—stomach cancer	0.000319	0.00277	CcSEcCtD
Alfentanil—Mediastinal disorder—Capecitabine—stomach cancer	0.000318	0.00276	CcSEcCtD
Alfentanil—Erythema—Docetaxel—stomach cancer	0.000317	0.00276	CcSEcCtD
Alfentanil—Chills—Capecitabine—stomach cancer	0.000317	0.00275	CcSEcCtD
Alfentanil—Arrhythmia—Capecitabine—stomach cancer	0.000315	0.00274	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—stomach cancer	0.000313	0.00272	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00031	0.00269	CcSEcCtD
Alfentanil—Mental disorder—Capecitabine—stomach cancer	0.000309	0.00269	CcSEcCtD
Alfentanil—Feeling abnormal—Irinotecan—stomach cancer	0.000309	0.00268	CcSEcCtD
Alfentanil—Erythema—Capecitabine—stomach cancer	0.000307	0.00267	CcSEcCtD
Alfentanil—Pain—Fluorouracil—stomach cancer	0.000307	0.00267	CcSEcCtD
Alfentanil—ABCB1—bone marrow—stomach cancer	0.000307	0.00816	CbGeAlD
Alfentanil—Body temperature increased—Irinotecan—stomach cancer	0.000296	0.00257	CcSEcCtD
Alfentanil—Feeling abnormal—Fluorouracil—stomach cancer	0.000296	0.00257	CcSEcCtD
Alfentanil—Drowsiness—Methotrexate—stomach cancer	0.000293	0.00254	CcSEcCtD
Alfentanil—Vision blurred—Capecitabine—stomach cancer	0.00029	0.00252	CcSEcCtD
Alfentanil—Urticaria—Fluorouracil—stomach cancer	0.000285	0.00248	CcSEcCtD
Alfentanil—Body temperature increased—Fluorouracil—stomach cancer	0.000284	0.00246	CcSEcCtD
Alfentanil—Loss of consciousness—Docetaxel—stomach cancer	0.000279	0.00242	CcSEcCtD
Alfentanil—Cough—Docetaxel—stomach cancer	0.000277	0.00241	CcSEcCtD
Alfentanil—Epistaxis—Methotrexate—stomach cancer	0.000276	0.0024	CcSEcCtD
Alfentanil—Hypersensitivity—Irinotecan—stomach cancer	0.000276	0.0024	CcSEcCtD
Alfentanil—Convulsion—Docetaxel—stomach cancer	0.000275	0.00239	CcSEcCtD
Alfentanil—ABCB1—endocrine gland—stomach cancer	0.000275	0.00731	CbGeAlD
Alfentanil—Hypertension—Docetaxel—stomach cancer	0.000274	0.00238	CcSEcCtD
Alfentanil—Drowsiness—Epirubicin—stomach cancer	0.000274	0.00238	CcSEcCtD
Alfentanil—Loss of consciousness—Capecitabine—stomach cancer	0.00027	0.00235	CcSEcCtD
Alfentanil—Asthenia—Irinotecan—stomach cancer	0.000269	0.00233	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000268	0.00233	CcSEcCtD
Alfentanil—Cough—Capecitabine—stomach cancer	0.000268	0.00233	CcSEcCtD
Alfentanil—Hypertension—Capecitabine—stomach cancer	0.000265	0.0023	CcSEcCtD
Alfentanil—Hypersensitivity—Fluorouracil—stomach cancer	0.000264	0.0023	CcSEcCtD
Alfentanil—Confusional state—Docetaxel—stomach cancer	0.000261	0.00227	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00026	0.00226	CcSEcCtD
Alfentanil—Anaphylactic shock—Docetaxel—stomach cancer	0.000259	0.00225	CcSEcCtD
Alfentanil—Epistaxis—Epirubicin—stomach cancer	0.000258	0.00224	CcSEcCtD
Alfentanil—Nervous system disorder—Docetaxel—stomach cancer	0.000254	0.00221	CcSEcCtD
Alfentanil—Pruritus—Fluorouracil—stomach cancer	0.000254	0.00221	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—stomach cancer	0.000253	0.0022	CcSEcCtD
Alfentanil—Visual impairment—Methotrexate—stomach cancer	0.000253	0.0022	CcSEcCtD
Alfentanil—Confusional state—Capecitabine—stomach cancer	0.000253	0.0022	CcSEcCtD
Alfentanil—Tachycardia—Docetaxel—stomach cancer	0.000253	0.0022	CcSEcCtD
Alfentanil—Skin disorder—Docetaxel—stomach cancer	0.000252	0.00219	CcSEcCtD
Alfentanil—Bradycardia—Epirubicin—stomach cancer	0.00025	0.00217	CcSEcCtD
Alfentanil—Dizziness—Irinotecan—stomach cancer	0.000248	0.00215	CcSEcCtD
Alfentanil—ABCB1—liver—stomach cancer	0.000248	0.00659	CbGeAlD
Alfentanil—Nervous system disorder—Capecitabine—stomach cancer	0.000246	0.00214	CcSEcCtD
Alfentanil—Eye disorder—Methotrexate—stomach cancer	0.000246	0.00213	CcSEcCtD
Alfentanil—Tachycardia—Capecitabine—stomach cancer	0.000245	0.00213	CcSEcCtD
Alfentanil—Cardiac disorder—Methotrexate—stomach cancer	0.000244	0.00212	CcSEcCtD
Alfentanil—Skin disorder—Capecitabine—stomach cancer	0.000244	0.00212	CcSEcCtD
Alfentanil—Hyperhidrosis—Capecitabine—stomach cancer	0.000242	0.00211	CcSEcCtD
Alfentanil—Hypotension—Docetaxel—stomach cancer	0.000242	0.0021	CcSEcCtD
Alfentanil—Connective tissue disorder—Epirubicin—stomach cancer	0.000242	0.0021	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—stomach cancer	0.000239	0.00208	CcSEcCtD
Alfentanil—Angiopathy—Methotrexate—stomach cancer	0.000238	0.00207	CcSEcCtD
Alfentanil—Vomiting—Irinotecan—stomach cancer	0.000238	0.00207	CcSEcCtD
Alfentanil—Immune system disorder—Methotrexate—stomach cancer	0.000237	0.00206	CcSEcCtD
Alfentanil—Dizziness—Fluorouracil—stomach cancer	0.000237	0.00206	CcSEcCtD
Alfentanil—Visual impairment—Epirubicin—stomach cancer	0.000237	0.00206	CcSEcCtD
Alfentanil—Mediastinal disorder—Methotrexate—stomach cancer	0.000237	0.00206	CcSEcCtD
Alfentanil—Rash—Irinotecan—stomach cancer	0.000236	0.00205	CcSEcCtD
Alfentanil—Dermatitis—Irinotecan—stomach cancer	0.000236	0.00205	CcSEcCtD
Alfentanil—Chills—Methotrexate—stomach cancer	0.000236	0.00205	CcSEcCtD
Alfentanil—Headache—Irinotecan—stomach cancer	0.000235	0.00204	CcSEcCtD
Alfentanil—Hypotension—Capecitabine—stomach cancer	0.000234	0.00204	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—stomach cancer	0.000232	0.00201	CcSEcCtD
Alfentanil—Somnolence—Docetaxel—stomach cancer	0.00023	0.002	CcSEcCtD
Alfentanil—Mental disorder—Methotrexate—stomach cancer	0.00023	0.002	CcSEcCtD
Alfentanil—Eye disorder—Epirubicin—stomach cancer	0.00023	0.002	CcSEcCtD
Alfentanil—Erythema—Methotrexate—stomach cancer	0.000229	0.00199	CcSEcCtD
Alfentanil—Cardiac disorder—Epirubicin—stomach cancer	0.000228	0.00198	CcSEcCtD
Alfentanil—Vomiting—Fluorouracil—stomach cancer	0.000228	0.00198	CcSEcCtD
Alfentanil—Rash—Fluorouracil—stomach cancer	0.000226	0.00197	CcSEcCtD
Alfentanil—Dermatitis—Fluorouracil—stomach cancer	0.000226	0.00196	CcSEcCtD
Alfentanil—Headache—Fluorouracil—stomach cancer	0.000225	0.00195	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000224	0.00194	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—stomach cancer	0.000224	0.00194	CcSEcCtD
Alfentanil—Fatigue—Docetaxel—stomach cancer	0.000223	0.00194	CcSEcCtD
Alfentanil—Angiopathy—Epirubicin—stomach cancer	0.000223	0.00194	CcSEcCtD
Alfentanil—Nausea—Irinotecan—stomach cancer	0.000223	0.00193	CcSEcCtD
Alfentanil—Immune system disorder—Epirubicin—stomach cancer	0.000222	0.00193	CcSEcCtD
Alfentanil—Mediastinal disorder—Epirubicin—stomach cancer	0.000222	0.00192	CcSEcCtD
Alfentanil—Pain—Docetaxel—stomach cancer	0.000221	0.00192	CcSEcCtD
Alfentanil—Chills—Epirubicin—stomach cancer	0.000221	0.00192	CcSEcCtD
Alfentanil—Arrhythmia—Epirubicin—stomach cancer	0.00022	0.00191	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—stomach cancer	0.000219	0.0019	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000216	0.00188	CcSEcCtD
Alfentanil—Fatigue—Capecitabine—stomach cancer	0.000216	0.00188	CcSEcCtD
Alfentanil—Vision blurred—Methotrexate—stomach cancer	0.000216	0.00187	CcSEcCtD
Alfentanil—Mental disorder—Epirubicin—stomach cancer	0.000215	0.00187	CcSEcCtD
Alfentanil—Pain—Capecitabine—stomach cancer	0.000214	0.00186	CcSEcCtD
Alfentanil—Erythema—Epirubicin—stomach cancer	0.000214	0.00186	CcSEcCtD
Alfentanil—Feeling abnormal—Docetaxel—stomach cancer	0.000213	0.00185	CcSEcCtD
Alfentanil—Nausea—Fluorouracil—stomach cancer	0.000213	0.00185	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—stomach cancer	0.000213	0.00185	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—stomach cancer	0.000211	0.00183	CcSEcCtD
Alfentanil—Feeling abnormal—Capecitabine—stomach cancer	0.000207	0.00179	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—stomach cancer	0.000206	0.00179	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—stomach cancer	0.000205	0.00178	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—stomach cancer	0.000205	0.00178	CcSEcCtD
Alfentanil—Body temperature increased—Docetaxel—stomach cancer	0.000205	0.00178	CcSEcCtD
Alfentanil—Chills—Doxorubicin—stomach cancer	0.000204	0.00177	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—stomach cancer	0.000203	0.00177	CcSEcCtD
Alfentanil—Vision blurred—Epirubicin—stomach cancer	0.000202	0.00175	CcSEcCtD
Alfentanil—Cough—Methotrexate—stomach cancer	0.0002	0.00173	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—stomach cancer	0.000199	0.00173	CcSEcCtD
Alfentanil—Urticaria—Capecitabine—stomach cancer	0.000199	0.00173	CcSEcCtD
Alfentanil—Body temperature increased—Capecitabine—stomach cancer	0.000198	0.00172	CcSEcCtD
Alfentanil—Convulsion—Methotrexate—stomach cancer	0.000198	0.00172	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—stomach cancer	0.000198	0.00172	CcSEcCtD
Alfentanil—Agitation—Epirubicin—stomach cancer	0.000197	0.00171	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000193	0.00168	CcSEcCtD
Alfentanil—Hypersensitivity—Docetaxel—stomach cancer	0.000191	0.00166	CcSEcCtD
Alfentanil—ABCB1—lymph node—stomach cancer	0.00019	0.00505	CbGeAlD
Alfentanil—Confusional state—Methotrexate—stomach cancer	0.000188	0.00163	CcSEcCtD
Alfentanil—Loss of consciousness—Epirubicin—stomach cancer	0.000188	0.00163	CcSEcCtD
Alfentanil—Cough—Epirubicin—stomach cancer	0.000187	0.00162	CcSEcCtD
Alfentanil—Anaphylactic shock—Methotrexate—stomach cancer	0.000187	0.00162	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—stomach cancer	0.000187	0.00162	CcSEcCtD
Alfentanil—Asthenia—Docetaxel—stomach cancer	0.000186	0.00161	CcSEcCtD
Alfentanil—Convulsion—Epirubicin—stomach cancer	0.000185	0.00161	CcSEcCtD
Alfentanil—Hypertension—Epirubicin—stomach cancer	0.000185	0.00161	CcSEcCtD
Alfentanil—Hypersensitivity—Capecitabine—stomach cancer	0.000185	0.0016	CcSEcCtD
Alfentanil—Pruritus—Docetaxel—stomach cancer	0.000183	0.00159	CcSEcCtD
Alfentanil—Nervous system disorder—Methotrexate—stomach cancer	0.000183	0.00159	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—stomach cancer	0.000182	0.00158	CcSEcCtD
Alfentanil—Skin disorder—Methotrexate—stomach cancer	0.000181	0.00157	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000181	0.00157	CcSEcCtD
Alfentanil—Hyperhidrosis—Methotrexate—stomach cancer	0.00018	0.00157	CcSEcCtD
Alfentanil—Asthenia—Capecitabine—stomach cancer	0.00018	0.00156	CcSEcCtD
Alfentanil—Pruritus—Capecitabine—stomach cancer	0.000177	0.00154	CcSEcCtD
Alfentanil—Confusional state—Epirubicin—stomach cancer	0.000176	0.00153	CcSEcCtD
Alfentanil—Anaphylactic shock—Epirubicin—stomach cancer	0.000175	0.00152	CcSEcCtD
Alfentanil—Hypotension—Methotrexate—stomach cancer	0.000174	0.00152	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—stomach cancer	0.000174	0.00151	CcSEcCtD
Alfentanil—Cough—Doxorubicin—stomach cancer	0.000173	0.0015	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—stomach cancer	0.000172	0.00149	CcSEcCtD
Alfentanil—Nervous system disorder—Epirubicin—stomach cancer	0.000171	0.00149	CcSEcCtD
Alfentanil—Dizziness—Docetaxel—stomach cancer	0.000171	0.00149	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—stomach cancer	0.000171	0.00149	CcSEcCtD
Alfentanil—Tachycardia—Epirubicin—stomach cancer	0.00017	0.00148	CcSEcCtD
Alfentanil—Skin disorder—Epirubicin—stomach cancer	0.00017	0.00147	CcSEcCtD
Alfentanil—Hyperhidrosis—Epirubicin—stomach cancer	0.000169	0.00147	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000167	0.00145	CcSEcCtD
Alfentanil—Somnolence—Methotrexate—stomach cancer	0.000166	0.00144	CcSEcCtD
Alfentanil—Dizziness—Capecitabine—stomach cancer	0.000166	0.00144	CcSEcCtD
Alfentanil—Vomiting—Docetaxel—stomach cancer	0.000165	0.00143	CcSEcCtD
Alfentanil—Rash—Docetaxel—stomach cancer	0.000163	0.00142	CcSEcCtD
Alfentanil—Hypotension—Epirubicin—stomach cancer	0.000163	0.00142	CcSEcCtD
Alfentanil—Dermatitis—Docetaxel—stomach cancer	0.000163	0.00142	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—stomach cancer	0.000163	0.00142	CcSEcCtD
Alfentanil—Headache—Docetaxel—stomach cancer	0.000162	0.00141	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—stomach cancer	0.000162	0.0014	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000161	0.0014	CcSEcCtD
Alfentanil—Fatigue—Methotrexate—stomach cancer	0.000161	0.0014	CcSEcCtD
Alfentanil—Pain—Methotrexate—stomach cancer	0.00016	0.00139	CcSEcCtD
Alfentanil—Vomiting—Capecitabine—stomach cancer	0.000159	0.00138	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—stomach cancer	0.000159	0.00138	CcSEcCtD
Alfentanil—Rash—Capecitabine—stomach cancer	0.000158	0.00137	CcSEcCtD
Alfentanil—Dermatitis—Capecitabine—stomach cancer	0.000158	0.00137	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—stomach cancer	0.000158	0.00137	CcSEcCtD
Alfentanil—Headache—Capecitabine—stomach cancer	0.000157	0.00136	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—stomach cancer	0.000157	0.00136	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—stomach cancer	0.000156	0.00136	CcSEcCtD
Alfentanil—Somnolence—Epirubicin—stomach cancer	0.000155	0.00135	CcSEcCtD
Alfentanil—Nausea—Docetaxel—stomach cancer	0.000154	0.00134	CcSEcCtD
Alfentanil—Feeling abnormal—Methotrexate—stomach cancer	0.000154	0.00134	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—stomach cancer	0.000151	0.00131	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000151	0.00131	CcSEcCtD
Alfentanil—Fatigue—Epirubicin—stomach cancer	0.000151	0.00131	CcSEcCtD
Alfentanil—Pain—Epirubicin—stomach cancer	0.000149	0.0013	CcSEcCtD
Alfentanil—Nausea—Capecitabine—stomach cancer	0.000149	0.00129	CcSEcCtD
Alfentanil—Urticaria—Methotrexate—stomach cancer	0.000148	0.00129	CcSEcCtD
Alfentanil—Body temperature increased—Methotrexate—stomach cancer	0.000148	0.00128	CcSEcCtD
Alfentanil—Feeling abnormal—Epirubicin—stomach cancer	0.000144	0.00125	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—stomach cancer	0.000144	0.00125	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00014	0.00121	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—stomach cancer	0.000139	0.00121	CcSEcCtD
Alfentanil—Urticaria—Epirubicin—stomach cancer	0.000139	0.00121	CcSEcCtD
Alfentanil—Pain—Doxorubicin—stomach cancer	0.000138	0.0012	CcSEcCtD
Alfentanil—Body temperature increased—Epirubicin—stomach cancer	0.000138	0.0012	CcSEcCtD
Alfentanil—Hypersensitivity—Methotrexate—stomach cancer	0.000138	0.00119	CcSEcCtD
Alfentanil—Asthenia—Methotrexate—stomach cancer	0.000134	0.00116	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—stomach cancer	0.000133	0.00116	CcSEcCtD
Alfentanil—Pruritus—Methotrexate—stomach cancer	0.000132	0.00115	CcSEcCtD
Alfentanil—Hypersensitivity—Epirubicin—stomach cancer	0.000129	0.00112	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—stomach cancer	0.000128	0.00112	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—stomach cancer	0.000128	0.00111	CcSEcCtD
Alfentanil—Asthenia—Epirubicin—stomach cancer	0.000125	0.00109	CcSEcCtD
Alfentanil—Pruritus—Epirubicin—stomach cancer	0.000124	0.00107	CcSEcCtD
Alfentanil—Dizziness—Methotrexate—stomach cancer	0.000123	0.00107	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—stomach cancer	0.000119	0.00103	CcSEcCtD
Alfentanil—Vomiting—Methotrexate—stomach cancer	0.000119	0.00103	CcSEcCtD
Alfentanil—Rash—Methotrexate—stomach cancer	0.000118	0.00102	CcSEcCtD
Alfentanil—Dermatitis—Methotrexate—stomach cancer	0.000118	0.00102	CcSEcCtD
Alfentanil—Headache—Methotrexate—stomach cancer	0.000117	0.00102	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—stomach cancer	0.000116	0.00101	CcSEcCtD
Alfentanil—Dizziness—Epirubicin—stomach cancer	0.000116	0.001	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—stomach cancer	0.000114	0.000993	CcSEcCtD
Alfentanil—Vomiting—Epirubicin—stomach cancer	0.000111	0.000965	CcSEcCtD
Alfentanil—Nausea—Methotrexate—stomach cancer	0.000111	0.000963	CcSEcCtD
Alfentanil—Rash—Epirubicin—stomach cancer	0.00011	0.000957	CcSEcCtD
Alfentanil—Dermatitis—Epirubicin—stomach cancer	0.00011	0.000956	CcSEcCtD
Alfentanil—Headache—Epirubicin—stomach cancer	0.000109	0.000951	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—stomach cancer	0.000107	0.000928	CcSEcCtD
Alfentanil—Nausea—Epirubicin—stomach cancer	0.000104	0.000901	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—stomach cancer	0.000103	0.000893	CcSEcCtD
Alfentanil—Rash—Doxorubicin—stomach cancer	0.000102	0.000885	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—stomach cancer	0.000102	0.000884	CcSEcCtD
Alfentanil—Headache—Doxorubicin—stomach cancer	0.000101	0.00088	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—stomach cancer	9.6e-05	0.000834	CcSEcCtD
Alfentanil—CYP3A7—Metabolism—CYP2A6—stomach cancer	5.77e-06	0.000606	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NT5E—stomach cancer	5.68e-06	0.000596	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PGAM1—stomach cancer	5.68e-06	0.000596	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SREBF2—stomach cancer	5.64e-06	0.000591	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKR1C3—stomach cancer	5.61e-06	0.000589	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AGTR2—stomach cancer	5.61e-06	0.000589	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HSPB1—stomach cancer	5.61e-06	0.000589	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—FYN—stomach cancer	5.59e-06	0.000586	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—IDH3B—stomach cancer	5.57e-06	0.000585	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SUCLG1—stomach cancer	5.57e-06	0.000585	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—RORA—stomach cancer	5.57e-06	0.000584	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	5.56e-06	0.000583	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—F2R—stomach cancer	5.55e-06	0.000582	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BMP2—stomach cancer	5.55e-06	0.000582	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	5.55e-06	0.000582	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PDHA1—stomach cancer	5.51e-06	0.000578	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ECHS1—stomach cancer	5.51e-06	0.000578	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ENO1—stomach cancer	5.47e-06	0.000574	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKR1C3—stomach cancer	5.46e-06	0.000573	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALDH7A1—stomach cancer	5.42e-06	0.000569	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PLCE1—stomach cancer	5.42e-06	0.000569	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR1A—stomach cancer	5.4e-06	0.000567	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.38e-06	0.000564	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	5.31e-06	0.000557	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.25e-06	0.000551	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PRKCB—stomach cancer	5.23e-06	0.000549	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALDOB—stomach cancer	5.22e-06	0.000548	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ANXA1—stomach cancer	5.22e-06	0.000547	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—UMPS—stomach cancer	5.2e-06	0.000545	CbGpPWpGaD
Alfentanil—ALB—Metabolism—FADS1—stomach cancer	5.18e-06	0.000544	CbGpPWpGaD
Alfentanil—ALB—Metabolism—TYMP—stomach cancer	5.18e-06	0.000544	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NDUFV1—stomach cancer	5.18e-06	0.000544	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NDUFS1—stomach cancer	5.18e-06	0.000544	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ADRB1—stomach cancer	5.05e-06	0.00053	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	4.92e-06	0.000516	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SREBF2—stomach cancer	4.85e-06	0.000509	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CD44—stomach cancer	4.85e-06	0.000509	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALOX5—stomach cancer	4.85e-06	0.000509	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	4.84e-06	0.000508	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ECHS1—stomach cancer	4.83e-06	0.000507	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PDHA1—stomach cancer	4.83e-06	0.000507	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RPS6—stomach cancer	4.83e-06	0.000506	CbGpPWpGaD
Alfentanil—ALB—Metabolism—RORA—stomach cancer	4.8e-06	0.000503	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—DPYD—stomach cancer	4.77e-06	0.000501	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PLAU—stomach cancer	4.77e-06	0.0005	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PRKCB—stomach cancer	4.75e-06	0.000498	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6ST—stomach cancer	4.73e-06	0.000496	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—CAV1—stomach cancer	4.66e-06	0.000488	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	4.65e-06	0.000488	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	4.65e-06	0.000488	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—APOA1—stomach cancer	4.64e-06	0.000487	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PGLS—stomach cancer	4.62e-06	0.000485	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—BLVRB—stomach cancer	4.62e-06	0.000485	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.58e-06	0.000481	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—TYMP—stomach cancer	4.54e-06	0.000477	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—FADS1—stomach cancer	4.54e-06	0.000477	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALDOB—stomach cancer	4.49e-06	0.000472	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.46e-06	0.000468	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HBEGF—stomach cancer	4.44e-06	0.000465	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PRKCB—stomach cancer	4.43e-06	0.000465	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	4.43e-06	0.000465	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPAP2A—stomach cancer	4.41e-06	0.000462	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.36e-06	0.000458	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.36e-06	0.000457	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SREBF2—stomach cancer	4.25e-06	0.000446	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.24e-06	0.000445	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.23e-06	0.000444	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTT1—stomach cancer	4.22e-06	0.000443	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6R—stomach cancer	4.22e-06	0.000443	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—RORA—stomach cancer	4.2e-06	0.000441	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—RHOA—stomach cancer	4.2e-06	0.00044	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALOX5—stomach cancer	4.18e-06	0.000438	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2A6—stomach cancer	4.17e-06	0.000438	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.15e-06	0.000436	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPP2R1A—stomach cancer	4.13e-06	0.000433	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.12e-06	0.000432	CbGpPWpGaD
Alfentanil—ALB—Metabolism—DPYD—stomach cancer	4.11e-06	0.000431	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ADRB2—stomach cancer	4.09e-06	0.00043	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKR1C3—stomach cancer	4.06e-06	0.000426	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTP1—stomach cancer	4.05e-06	0.000425	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	4.02e-06	0.000422	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PPP2R1A—stomach cancer	4.01e-06	0.000421	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—HMOX1—stomach cancer	3.99e-06	0.000419	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ENO1—stomach cancer	3.96e-06	0.000415	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALDOB—stomach cancer	3.94e-06	0.000413	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FBP1—stomach cancer	3.93e-06	0.000412	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.93e-06	0.000412	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CKB—stomach cancer	3.93e-06	0.000412	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CA1—stomach cancer	3.93e-06	0.000412	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	3.84e-06	0.000403	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—RHOA—stomach cancer	3.81e-06	0.0004	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.78e-06	0.000397	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—TYMS—stomach cancer	3.76e-06	0.000395	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.73e-06	0.000391	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SMAD4—stomach cancer	3.72e-06	0.000391	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTM1—stomach cancer	3.72e-06	0.00039	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLIN2—stomach cancer	3.69e-06	0.000387	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SERPINE1—stomach cancer	3.69e-06	0.000387	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CXCL8—stomach cancer	3.69e-06	0.000387	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALOX5—stomach cancer	3.66e-06	0.000384	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.66e-06	0.000384	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTT1—stomach cancer	3.64e-06	0.000381	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—DPYD—stomach cancer	3.6e-06	0.000378	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2A6—stomach cancer	3.59e-06	0.000377	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CA2—stomach cancer	3.59e-06	0.000377	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—RHOA—stomach cancer	3.56e-06	0.000373	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FYN—stomach cancer	3.54e-06	0.000371	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.52e-06	0.00037	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS3—stomach cancer	3.52e-06	0.000369	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CD44—stomach cancer	3.51e-06	0.000368	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NT5E—stomach cancer	3.5e-06	0.000367	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PGAM1—stomach cancer	3.5e-06	0.000367	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ERCC2—stomach cancer	3.5e-06	0.000367	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKR1C3—stomach cancer	3.5e-06	0.000367	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ENO1—stomach cancer	3.41e-06	0.000357	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCL8—stomach cancer	3.35e-06	0.000351	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLCE1—stomach cancer	3.34e-06	0.00035	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.34e-06	0.00035	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGFR2—stomach cancer	3.32e-06	0.000348	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MTHFR—stomach cancer	3.29e-06	0.000345	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—UMPS—stomach cancer	3.2e-06	0.000336	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTT1—stomach cancer	3.18e-06	0.000334	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2A6—stomach cancer	3.15e-06	0.00033	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKR1C3—stomach cancer	3.06e-06	0.000321	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IRS2—stomach cancer	3.04e-06	0.000319	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CAV1—stomach cancer	3.03e-06	0.000318	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOA1—stomach cancer	3.03e-06	0.000317	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CD44—stomach cancer	3.02e-06	0.000317	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ENO1—stomach cancer	2.98e-06	0.000313	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPP2R1A—stomach cancer	2.98e-06	0.000313	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ECHS1—stomach cancer	2.98e-06	0.000312	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PDHA1—stomach cancer	2.98e-06	0.000312	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CAV1—stomach cancer	2.95e-06	0.000309	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOA1—stomach cancer	2.94e-06	0.000309	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.93e-06	0.000308	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTP1—stomach cancer	2.93e-06	0.000307	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMOX1—stomach cancer	2.89e-06	0.000303	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PRKCB—stomach cancer	2.81e-06	0.000294	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TYMP—stomach cancer	2.8e-06	0.000294	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FADS1—stomach cancer	2.8e-06	0.000294	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6ST—stomach cancer	2.79e-06	0.000293	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.79e-06	0.000293	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—TYMS—stomach cancer	2.72e-06	0.000285	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTM1—stomach cancer	2.69e-06	0.000282	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APC—stomach cancer	2.69e-06	0.000282	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARG—stomach cancer	2.67e-06	0.00028	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CD44—stomach cancer	2.65e-06	0.000278	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SREBF2—stomach cancer	2.62e-06	0.000275	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—RORA—stomach cancer	2.59e-06	0.000272	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MAPK3—stomach cancer	2.57e-06	0.00027	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPP2R1A—stomach cancer	2.57e-06	0.00027	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—stomach cancer	2.54e-06	0.000266	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ERCC2—stomach cancer	2.53e-06	0.000265	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTP1—stomach cancer	2.52e-06	0.000264	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6R—stomach cancer	2.49e-06	0.000262	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMOX1—stomach cancer	2.48e-06	0.000261	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MAPK1—stomach cancer	2.45e-06	0.000257	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—EGFR—stomach cancer	2.45e-06	0.000257	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDOB—stomach cancer	2.43e-06	0.000255	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAPK3—stomach cancer	2.4e-06	0.000252	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—stomach cancer	2.4e-06	0.000251	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MTHFR—stomach cancer	2.38e-06	0.000249	CbGpPWpGaD
Alfentanil—ALB—Metabolism—TYMS—stomach cancer	2.34e-06	0.000246	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CA—stomach cancer	2.34e-06	0.000245	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SERPINE1—stomach cancer	2.33e-06	0.000245	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTM1—stomach cancer	2.32e-06	0.000243	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—KRAS—stomach cancer	2.31e-06	0.000242	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NOS3—stomach cancer	2.29e-06	0.000241	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAPK1—stomach cancer	2.28e-06	0.00024	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALOX5—stomach cancer	2.26e-06	0.000237	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RHOA—stomach cancer	2.25e-06	0.000236	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPP2R1A—stomach cancer	2.25e-06	0.000236	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOS3—stomach cancer	2.23e-06	0.000234	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—DPYD—stomach cancer	2.22e-06	0.000233	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTP1—stomach cancer	2.21e-06	0.000232	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CAV1—stomach cancer	2.19e-06	0.00023	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOA1—stomach cancer	2.19e-06	0.000229	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMOX1—stomach cancer	2.18e-06	0.000228	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ERCC2—stomach cancer	2.18e-06	0.000228	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—KRAS—stomach cancer	2.16e-06	0.000226	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CA—stomach cancer	2.12e-06	0.000223	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—stomach cancer	2.1e-06	0.00022	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ERBB2—stomach cancer	2.08e-06	0.000219	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—TYMS—stomach cancer	2.05e-06	0.000215	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MTHFR—stomach cancer	2.05e-06	0.000215	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTM1—stomach cancer	2.03e-06	0.000213	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CA—stomach cancer	1.98e-06	0.000208	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL8—stomach cancer	1.98e-06	0.000207	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HRAS—stomach cancer	1.96e-06	0.000206	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTT1—stomach cancer	1.96e-06	0.000206	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.94e-06	0.000204	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1B—stomach cancer	1.93e-06	0.000203	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARG—stomach cancer	1.93e-06	0.000202	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TP53—stomach cancer	1.92e-06	0.000201	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ERCC2—stomach cancer	1.91e-06	0.0002	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CAV1—stomach cancer	1.89e-06	0.000198	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.89e-06	0.000198	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOA1—stomach cancer	1.88e-06	0.000198	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—stomach cancer	1.88e-06	0.000197	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCND1—stomach cancer	1.84e-06	0.000193	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ENO1—stomach cancer	1.84e-06	0.000193	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JUN—stomach cancer	1.84e-06	0.000193	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—HRAS—stomach cancer	1.83e-06	0.000192	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.8e-06	0.000189	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MTHFR—stomach cancer	1.79e-06	0.000188	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—stomach cancer	1.79e-06	0.000188	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1A—stomach cancer	1.78e-06	0.000187	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK8—stomach cancer	1.74e-06	0.000182	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—stomach cancer	1.73e-06	0.000182	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARG—stomach cancer	1.66e-06	0.000174	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NOS3—stomach cancer	1.66e-06	0.000174	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CAV1—stomach cancer	1.65e-06	0.000174	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOA1—stomach cancer	1.65e-06	0.000173	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CD44—stomach cancer	1.63e-06	0.000171	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—stomach cancer	1.61e-06	0.000168	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—STAT3—stomach cancer	1.59e-06	0.000167	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK3—stomach cancer	1.52e-06	0.000159	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—stomach cancer	1.52e-06	0.000159	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MYC—stomach cancer	1.48e-06	0.000155	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARG—stomach cancer	1.45e-06	0.000153	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK1—stomach cancer	1.45e-06	0.000152	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EGFR—stomach cancer	1.45e-06	0.000152	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NOS3—stomach cancer	1.43e-06	0.00015	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.39e-06	0.000145	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KRAS—stomach cancer	1.37e-06	0.000143	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTP1—stomach cancer	1.36e-06	0.000143	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMOX1—stomach cancer	1.34e-06	0.000141	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—stomach cancer	1.31e-06	0.000137	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—stomach cancer	1.31e-06	0.000137	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CA—stomach cancer	1.29e-06	0.000135	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TYMS—stomach cancer	1.26e-06	0.000133	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CA—stomach cancer	1.25e-06	0.000132	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NOS3—stomach cancer	1.25e-06	0.000131	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTM1—stomach cancer	1.25e-06	0.000131	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TP53—stomach cancer	1.21e-06	0.000127	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ERCC2—stomach cancer	1.18e-06	0.000123	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HRAS—stomach cancer	1.16e-06	0.000122	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—stomach cancer	1.14e-06	0.00012	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—stomach cancer	1.11e-06	0.000117	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTHFR—stomach cancer	1.1e-06	0.000116	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CAV1—stomach cancer	1.02e-06	0.000107	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOA1—stomach cancer	1.02e-06	0.000107	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CA—stomach cancer	9.33e-07	9.78e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARG—stomach cancer	8.96e-07	9.4e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—stomach cancer	8.05e-07	8.45e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CA—stomach cancer	8.03e-07	8.43e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NOS3—stomach cancer	7.7e-07	8.08e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—stomach cancer	7.05e-07	7.39e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CA—stomach cancer	7.04e-07	7.38e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CA—stomach cancer	4.34e-07	4.55e-05	CbGpPWpGaD
